Email Printer Friendly
Elekta launches new Versa HD linear accelerator
By AuntMinnieEurope.com staff writers
March 1, 2013

Radiation oncology firm Elekta has launched a new advanced linear accelerator system, Versa HD.

The new system features high-precision beam shaping and tumor targeting, the company said during a global press conference launch on March 1. It is designed to deliver conventional treatments for a wide range of tumors throughout the body, as well as specialized treatments that require extreme targeting precision.

Versa HD is integrated with the Agility 160-leaf multileaf collimator, providing highly conformal beam shaping, a critical requirement for maximizing radiation dose to the target while also preserving surrounding healthy tissues. Its high targeting accuracy is available over a large field-of-view, permitting delivery of high-definition beams to a wide spectrum of complex targets, according to the company.

Versa HD is capable of delivering radiation doses three times faster than previous generations of Elekta linear accelerators. However, it consumes up to 30% less energy than other radiation therapy delivery systems, the firm said. The new linear accelerator also features new user controls, ambient lighting effects, and a sleeker exterior.

Elekta promotes prostate brachytherapy treatment, February 12, 2013

Elekta announces radiation therapy progress in Iraq, February 11, 2013

Elekta expands radiotherapy business in the U.K., February 5, 2013

Elekta reports treatment milestone in Italy, January 23, 2013

Elekta, Philips expand imaging venture, October 25, 2012


Copyright © 2013 AuntMinnieEurope.com

Last Updated np 3/1/2013 10:35:32 AM

Email Printer Friendly


|| About || Advertising || Case of the Week || Communities || Conferences || Contact Us || ECR News 2013 || Education || Facebook || Forums || Home || JFR News || Links || Mobile || New Installations || News in Brief || Privacy Policy || Twitter || Vendor Connect || Webinars || XML/RSS ||

Copyright © 2013 AuntMinnieEurope.com. All Rights Reserved.